Metabolomic Study for Localized Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- Radiation: Radiation Therapy
- Registration Number
- NCT01968538
- Lead Sponsor
- Georgetown University
- Brief Summary
Prostate cancer is a common disease in men treated using surgery, radiation therapy and/or hormonal therapy. Clinical prognosis relates to stage and grade of disease. Recent advances in omic analysis may offer additional information to the physician about prognosis and radiation response. We propose to establish a protocol to incorporate omic analysis into the evaluation and treatment of patients with prostate cancer.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- Male
- Target Recruitment
- 400
Inclusion Criteria
- Males who are older than 18 years old,
- with clinically localized prostate cancer
- are receiving radiation therapy
Exclusion Criteria
- none
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Prostate Cancer Patients Radiation Therapy Prostate cancer patients who underwent radiation therapy
- Primary Outcome Measures
Name Time Method molecular changes in biofluid 5 years
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Georgetown University Hospital
🇺🇸Arlington, Virginia, United States